No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Established in 1989 and headquartered in Kolkata, India, Sastasundar Ventures Limited manages a comprehensive digital healthcare ecosystem across the country. In addition to its core healthcare activities, the company provides a variety of financial services, including loan financing, investments in shares and other securities, financial advisory, wealth management, and distribution. It also runs online portals such as sastasundar.com and retailershakti.com for the promotion of healthcare products and pathology services. Furthermore, Sastasundar offers crucial diagnostic services, encompassing both pathological and radiological investigations. Its business also extends to distributing pharmaceuticals and wellness items, delivering personalized health supplements, offering diet counseling, and providing health information. The company adopted its current name, Sastasundar Ventures Limited, in November 2016, having previously operated as Microsec Financial Services Limited.
www.sastasundarventures.comNo one on the platform currently holds SASTASUNDR.NS.
No tracked institution reports a position in SASTASUNDR.NS as of their last filing.
No one on the platform has traded SASTASUNDR.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $33.4B | +27.7% | $-17.60 | $-17.60–$-17.60 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 5 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-05-30 | $-4.20 | $4.21 | +200.2% |
| 2025-05-28 | $-4.20 | $4.30 | +202.4% |
| 2025-02-14 | $2.90 | $-7.76 | -367.6% |
| 2024-11-15 | $1.80 | $-34.40 | -2011.1% |
| 2024-05-31 | $-5.60 | $9.48 | +269.3% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| SASTASUNDR.NSSastasundar Ventures Limited | $282.60 | — | $9.0B | — |
| ANUHPHR.BOAnuh Pharma Limited | $89.42 | -0.81% | $9.0B | — |
| BPLPHARMA.BOBharat Parenterals Limited | $1517.05 | -2.13% | $10.5B | — |
| FREDUN.BOFredun Pharmaceuticals Limited | $1221.60 | -7.81% | $20.2B | — |
| KPL.BOKwality Pharmaceuticals Limited |
| $3348.05 |
| -2.81% |
| $34.7B |
| — |
| MAXIND.NSMax India Limited | $139.64 | +0.37% | $7.3B | — |
| NGLFINE.BONGL Fine-Chem Limited | $2679.90 | +4.58% | $16.3B | — |
Source: Financial Modeling Prep · peers by sector/industry